nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—lung cancer	0.411	1	CbGaD
Alosetron—CYP2C9—Gefitinib—lung cancer	0.0363	0.107	CbGbCtD
Alosetron—CYP2C9—Teniposide—lung cancer	0.0352	0.103	CbGbCtD
Alosetron—CYP2E1—Etoposide—lung cancer	0.0298	0.0876	CbGbCtD
Alosetron—CYP1A2—Erlotinib—lung cancer	0.0238	0.07	CbGbCtD
Alosetron—CYP3A4—Topotecan—lung cancer	0.0231	0.0678	CbGbCtD
Alosetron—CYP3A4—Gefitinib—lung cancer	0.0211	0.062	CbGbCtD
Alosetron—CYP3A4—Teniposide—lung cancer	0.0205	0.0602	CbGbCtD
Alosetron—CYP2C9—Paclitaxel—lung cancer	0.0197	0.0577	CbGbCtD
Alosetron—CYP1A2—Etoposide—lung cancer	0.0172	0.0506	CbGbCtD
Alosetron—CYP3A4—Vinorelbine—lung cancer	0.0163	0.0478	CbGbCtD
Alosetron—CYP2C9—Cisplatin—lung cancer	0.0158	0.0464	CbGbCtD
Alosetron—CYP3A4—Crizotinib—lung cancer	0.0129	0.038	CbGbCtD
Alosetron—CYP3A4—Erlotinib—lung cancer	0.0125	0.0367	CbGbCtD
Alosetron—CYP3A4—Paclitaxel—lung cancer	0.0114	0.0336	CbGbCtD
Alosetron—CYP3A4—Irinotecan—lung cancer	0.0113	0.0331	CbGbCtD
Alosetron—CYP3A4—Vinblastine—lung cancer	0.01	0.0294	CbGbCtD
Alosetron—CYP3A4—Etoposide—lung cancer	0.00903	0.0265	CbGbCtD
Alosetron—CYP3A4—Docetaxel—lung cancer	0.00826	0.0243	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—lung cancer	0.00616	0.0181	CbGbCtD
Alosetron—Ondansetron—CYP2E1—lung cancer	0.00214	1	CrCbGaD
Alosetron—Ill-defined disorder—Irinotecan—lung cancer	0.00019	0.00105	CcSEcCtD
Alosetron—Nausea—Teniposide—lung cancer	0.00019	0.00105	CcSEcCtD
Alosetron—Alopecia—Cisplatin—lung cancer	0.000189	0.00104	CcSEcCtD
Alosetron—Urticaria—Topotecan—lung cancer	0.000189	0.00104	CcSEcCtD
Alosetron—Ill-defined disorder—Gemcitabine—lung cancer	0.000185	0.00102	CcSEcCtD
Alosetron—Malaise—Irinotecan—lung cancer	0.000185	0.00102	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000185	0.00102	CcSEcCtD
Alosetron—Flatulence—Cisplatin—lung cancer	0.000184	0.00101	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—lung cancer	0.000183	0.00101	CcSEcCtD
Alosetron—Malaise—Gemcitabine—lung cancer	0.00018	0.000996	CcSEcCtD
Alosetron—Hypersensitivity—Vinblastine—lung cancer	0.00018	0.000994	CcSEcCtD
Alosetron—Muscle spasms—Cisplatin—lung cancer	0.000179	0.000989	CcSEcCtD
Alosetron—Cough—Irinotecan—lung cancer	0.000179	0.000989	CcSEcCtD
Alosetron—Hypertension—Irinotecan—lung cancer	0.000177	0.000979	CcSEcCtD
Alosetron—Jaundice—Docetaxel—lung cancer	0.000177	0.000977	CcSEcCtD
Alosetron—Asthenia—Vinblastine—lung cancer	0.000175	0.000968	CcSEcCtD
Alosetron—Fatigue—Vinorelbine—lung cancer	0.000175	0.000967	CcSEcCtD
Alosetron—Hypersensitivity—Topotecan—lung cancer	0.000175	0.000966	CcSEcCtD
Alosetron—Tremor—Cisplatin—lung cancer	0.000175	0.000964	CcSEcCtD
Alosetron—Cough—Gemcitabine—lung cancer	0.000174	0.000963	CcSEcCtD
Alosetron—Constipation—Vinorelbine—lung cancer	0.000174	0.000959	CcSEcCtD
Alosetron—Pain—Vinorelbine—lung cancer	0.000174	0.000959	CcSEcCtD
Alosetron—Alopecia—Etoposide—lung cancer	0.000173	0.000957	CcSEcCtD
Alosetron—Ill-defined disorder—Cisplatin—lung cancer	0.000173	0.000955	CcSEcCtD
Alosetron—Discomfort—Irinotecan—lung cancer	0.000173	0.000953	CcSEcCtD
Alosetron—Hypertension—Gemcitabine—lung cancer	0.000173	0.000953	CcSEcCtD
Alosetron—Arrhythmia—Paclitaxel—lung cancer	0.000172	0.000949	CcSEcCtD
Alosetron—Asthenia—Topotecan—lung cancer	0.00017	0.000941	CcSEcCtD
Alosetron—Myalgia—Gemcitabine—lung cancer	0.00017	0.00094	CcSEcCtD
Alosetron—Alopecia—Paclitaxel—lung cancer	0.00017	0.000938	CcSEcCtD
Alosetron—Confusional state—Irinotecan—lung cancer	0.000169	0.000933	CcSEcCtD
Alosetron—Asthenia—Erlotinib—lung cancer	0.000168	0.000931	CcSEcCtD
Alosetron—Discomfort—Gemcitabine—lung cancer	0.000168	0.000929	CcSEcCtD
Alosetron—Malaise—Cisplatin—lung cancer	0.000168	0.000928	CcSEcCtD
Alosetron—Feeling abnormal—Vinorelbine—lung cancer	0.000167	0.000924	CcSEcCtD
Alosetron—Infection—Irinotecan—lung cancer	0.000166	0.000919	CcSEcCtD
Alosetron—Flatulence—Paclitaxel—lung cancer	0.000165	0.000911	CcSEcCtD
Alosetron—Muscle spasms—Etoposide—lung cancer	0.000164	0.000906	CcSEcCtD
Alosetron—Haemoglobin—Docetaxel—lung cancer	0.000164	0.000905	CcSEcCtD
Alosetron—Eczema—Doxorubicin—lung cancer	0.000164	0.000904	CcSEcCtD
Alosetron—Haemorrhage—Docetaxel—lung cancer	0.000163	0.0009	CcSEcCtD
Alosetron—Hepatitis—Docetaxel—lung cancer	0.000163	0.0009	CcSEcCtD
Alosetron—Hypoaesthesia—Docetaxel—lung cancer	0.000162	0.000896	CcSEcCtD
Alosetron—Infection—Gemcitabine—lung cancer	0.000162	0.000895	CcSEcCtD
Alosetron—Hyperhidrosis—Irinotecan—lung cancer	0.000162	0.000894	CcSEcCtD
Alosetron—Urticaria—Vinorelbine—lung cancer	0.000161	0.000891	CcSEcCtD
Alosetron—Muscle spasms—Paclitaxel—lung cancer	0.000161	0.000889	CcSEcCtD
Alosetron—Myalgia—Cisplatin—lung cancer	0.000159	0.000876	CcSEcCtD
Alosetron—Skin disorder—Gemcitabine—lung cancer	0.000158	0.000875	CcSEcCtD
Alosetron—Ill-defined disorder—Etoposide—lung cancer	0.000158	0.000875	CcSEcCtD
Alosetron—Anxiety—Cisplatin—lung cancer	0.000158	0.000873	CcSEcCtD
Alosetron—Hyperhidrosis—Gemcitabine—lung cancer	0.000158	0.000871	CcSEcCtD
Alosetron—Tremor—Paclitaxel—lung cancer	0.000157	0.000866	CcSEcCtD
Alosetron—Discomfort—Cisplatin—lung cancer	0.000157	0.000866	CcSEcCtD
Alosetron—Vomiting—Vinblastine—lung cancer	0.000155	0.000858	CcSEcCtD
Alosetron—Ill-defined disorder—Paclitaxel—lung cancer	0.000155	0.000858	CcSEcCtD
Alosetron—Malaise—Etoposide—lung cancer	0.000154	0.00085	CcSEcCtD
Alosetron—Headache—Vinblastine—lung cancer	0.000153	0.000846	CcSEcCtD
Alosetron—Infection—Cisplatin—lung cancer	0.000151	0.000834	CcSEcCtD
Alosetron—Vomiting—Topotecan—lung cancer	0.000151	0.000834	CcSEcCtD
Alosetron—Malaise—Paclitaxel—lung cancer	0.000151	0.000834	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—lung cancer	0.000151	0.000832	CcSEcCtD
Alosetron—Rash—Topotecan—lung cancer	0.00015	0.000827	CcSEcCtD
Alosetron—Hypersensitivity—Vinorelbine—lung cancer	0.00015	0.000826	CcSEcCtD
Alosetron—Dermatitis—Topotecan—lung cancer	0.00015	0.000826	CcSEcCtD
Alosetron—Vomiting—Erlotinib—lung cancer	0.000149	0.000825	CcSEcCtD
Alosetron—Cough—Etoposide—lung cancer	0.000149	0.000823	CcSEcCtD
Alosetron—Headache—Topotecan—lung cancer	0.000149	0.000821	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000149	0.000821	CcSEcCtD
Alosetron—Rash—Erlotinib—lung cancer	0.000148	0.000818	CcSEcCtD
Alosetron—Dermatitis—Erlotinib—lung cancer	0.000148	0.000817	CcSEcCtD
Alosetron—Skin disorder—Cisplatin—lung cancer	0.000148	0.000816	CcSEcCtD
Alosetron—Hypertension—Etoposide—lung cancer	0.000147	0.000814	CcSEcCtD
Alosetron—Headache—Erlotinib—lung cancer	0.000147	0.000813	CcSEcCtD
Alosetron—Hyperhidrosis—Cisplatin—lung cancer	0.000147	0.000812	CcSEcCtD
Alosetron—Cough—Paclitaxel—lung cancer	0.000146	0.000807	CcSEcCtD
Alosetron—Asthenia—Vinorelbine—lung cancer	0.000146	0.000805	CcSEcCtD
Alosetron—Arrhythmia—Docetaxel—lung cancer	0.000146	0.000804	CcSEcCtD
Alosetron—Nausea—Vinblastine—lung cancer	0.000145	0.000802	CcSEcCtD
Alosetron—Hypertension—Paclitaxel—lung cancer	0.000144	0.000798	CcSEcCtD
Alosetron—Fatigue—Irinotecan—lung cancer	0.000144	0.000798	CcSEcCtD
Alosetron—Alopecia—Docetaxel—lung cancer	0.000144	0.000795	CcSEcCtD
Alosetron—Discomfort—Etoposide—lung cancer	0.000144	0.000793	CcSEcCtD
Alosetron—Constipation—Irinotecan—lung cancer	0.000143	0.000791	CcSEcCtD
Alosetron—Pain—Irinotecan—lung cancer	0.000143	0.000791	CcSEcCtD
Alosetron—Myalgia—Paclitaxel—lung cancer	0.000142	0.000787	CcSEcCtD
Alosetron—Anxiety—Paclitaxel—lung cancer	0.000142	0.000784	CcSEcCtD
Alosetron—Nausea—Topotecan—lung cancer	0.000141	0.000779	CcSEcCtD
Alosetron—Discomfort—Paclitaxel—lung cancer	0.000141	0.000778	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—lung cancer	0.000141	0.000777	CcSEcCtD
Alosetron—Fatigue—Gemcitabine—lung cancer	0.000141	0.000777	CcSEcCtD
Alosetron—Confusional state—Etoposide—lung cancer	0.00014	0.000776	CcSEcCtD
Alosetron—Constipation—Gemcitabine—lung cancer	0.000139	0.000771	CcSEcCtD
Alosetron—Pain—Gemcitabine—lung cancer	0.000139	0.000771	CcSEcCtD
Alosetron—Nausea—Erlotinib—lung cancer	0.000139	0.000771	CcSEcCtD
Alosetron—Dry mouth—Paclitaxel—lung cancer	0.000139	0.00077	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000139	0.000765	CcSEcCtD
Alosetron—Infection—Etoposide—lung cancer	0.000138	0.000764	CcSEcCtD
Alosetron—Feeling abnormal—Irinotecan—lung cancer	0.000138	0.000762	CcSEcCtD
Alosetron—Confusional state—Paclitaxel—lung cancer	0.000138	0.000761	CcSEcCtD
Alosetron—Muscle spasms—Docetaxel—lung cancer	0.000136	0.000753	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—lung cancer	0.000136	0.000753	CcSEcCtD
Alosetron—Infection—Paclitaxel—lung cancer	0.000136	0.000749	CcSEcCtD
Alosetron—Skin disorder—Etoposide—lung cancer	0.000135	0.000747	CcSEcCtD
Alosetron—Hyperhidrosis—Etoposide—lung cancer	0.000135	0.000744	CcSEcCtD
Alosetron—Feeling abnormal—Gemcitabine—lung cancer	0.000134	0.000743	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—lung cancer	0.000134	0.000742	CcSEcCtD
Alosetron—Skin disorder—Paclitaxel—lung cancer	0.000133	0.000733	CcSEcCtD
Alosetron—Hyperhidrosis—Paclitaxel—lung cancer	0.000132	0.000729	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—lung cancer	0.000131	0.000726	CcSEcCtD
Alosetron—Depression—Methotrexate—lung cancer	0.00013	0.000721	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—lung cancer	0.00013	0.000719	CcSEcCtD
Alosetron—Pain—Cisplatin—lung cancer	0.00013	0.000718	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.00013	0.000716	CcSEcCtD
Alosetron—Vomiting—Vinorelbine—lung cancer	0.000129	0.000713	CcSEcCtD
Alosetron—Rash—Vinorelbine—lung cancer	0.000128	0.000707	CcSEcCtD
Alosetron—Dermatitis—Vinorelbine—lung cancer	0.000128	0.000707	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—lung cancer	0.000128	0.000706	CcSEcCtD
Alosetron—Headache—Vinorelbine—lung cancer	0.000127	0.000703	CcSEcCtD
Alosetron—Sweating—Methotrexate—lung cancer	0.000125	0.000693	CcSEcCtD
Alosetron—Feeling abnormal—Cisplatin—lung cancer	0.000125	0.000692	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000124	0.000687	CcSEcCtD
Alosetron—Cough—Docetaxel—lung cancer	0.000124	0.000684	CcSEcCtD
Alosetron—Hypersensitivity—Irinotecan—lung cancer	0.000123	0.000682	CcSEcCtD
Alosetron—Hypertension—Docetaxel—lung cancer	0.000122	0.000676	CcSEcCtD
Alosetron—Myalgia—Docetaxel—lung cancer	0.000121	0.000667	CcSEcCtD
Alosetron—Nausea—Vinorelbine—lung cancer	0.000121	0.000666	CcSEcCtD
Alosetron—Asthenia—Irinotecan—lung cancer	0.00012	0.000664	CcSEcCtD
Alosetron—Fatigue—Etoposide—lung cancer	0.00012	0.000663	CcSEcCtD
Alosetron—Pain—Etoposide—lung cancer	0.000119	0.000658	CcSEcCtD
Alosetron—Constipation—Etoposide—lung cancer	0.000119	0.000658	CcSEcCtD
Alosetron—Dry mouth—Docetaxel—lung cancer	0.000118	0.000652	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000118	0.000652	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—lung cancer	0.000118	0.000652	CcSEcCtD
Alosetron—Fatigue—Paclitaxel—lung cancer	0.000118	0.00065	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—lung cancer	0.000117	0.000649	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—lung cancer	0.000117	0.000649	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—lung cancer	0.000117	0.000648	CcSEcCtD
Alosetron—Asthenia—Gemcitabine—lung cancer	0.000117	0.000646	CcSEcCtD
Alosetron—Pain—Paclitaxel—lung cancer	0.000117	0.000645	CcSEcCtD
Alosetron—Constipation—Paclitaxel—lung cancer	0.000117	0.000645	CcSEcCtD
Alosetron—Confusional state—Docetaxel—lung cancer	0.000117	0.000645	CcSEcCtD
Alosetron—Infection—Docetaxel—lung cancer	0.000115	0.000635	CcSEcCtD
Alosetron—Feeling abnormal—Etoposide—lung cancer	0.000115	0.000634	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—lung cancer	0.000115	0.000633	CcSEcCtD
Alosetron—Feeling abnormal—Paclitaxel—lung cancer	0.000113	0.000622	CcSEcCtD
Alosetron—Skin disorder—Docetaxel—lung cancer	0.000112	0.000621	CcSEcCtD
Alosetron—Hypersensitivity—Cisplatin—lung cancer	0.000112	0.000619	CcSEcCtD
Alosetron—Urticaria—Etoposide—lung cancer	0.000111	0.000611	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—lung cancer	0.00011	0.00061	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—lung cancer	0.00011	0.000608	CcSEcCtD
Alosetron—Asthenia—Cisplatin—lung cancer	0.000109	0.000603	CcSEcCtD
Alosetron—Sweating—Doxorubicin—lung cancer	0.000109	0.0006	CcSEcCtD
Alosetron—Urticaria—Paclitaxel—lung cancer	0.000108	0.000599	CcSEcCtD
Alosetron—Vomiting—Irinotecan—lung cancer	0.000106	0.000588	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—lung cancer	0.000106	0.000587	CcSEcCtD
Alosetron—Rash—Irinotecan—lung cancer	0.000106	0.000583	CcSEcCtD
Alosetron—Dermatitis—Irinotecan—lung cancer	0.000105	0.000583	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000105	0.000583	CcSEcCtD
Alosetron—Headache—Irinotecan—lung cancer	0.000105	0.000579	CcSEcCtD
Alosetron—Alopecia—Methotrexate—lung cancer	0.000104	0.000573	CcSEcCtD
Alosetron—Vomiting—Gemcitabine—lung cancer	0.000104	0.000573	CcSEcCtD
Alosetron—Rash—Gemcitabine—lung cancer	0.000103	0.000568	CcSEcCtD
Alosetron—Dermatitis—Gemcitabine—lung cancer	0.000103	0.000568	CcSEcCtD
Alosetron—Hypersensitivity—Etoposide—lung cancer	0.000103	0.000567	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—lung cancer	0.000102	0.000565	CcSEcCtD
Alosetron—Headache—Gemcitabine—lung cancer	0.000102	0.000564	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—lung cancer	0.000102	0.000562	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—lung cancer	0.000102	0.000562	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—lung cancer	0.000101	0.000559	CcSEcCtD
Alosetron—Hypersensitivity—Paclitaxel—lung cancer	0.000101	0.000556	CcSEcCtD
Alosetron—Asthenia—Etoposide—lung cancer	9.99e-05	0.000552	CcSEcCtD
Alosetron—Fatigue—Docetaxel—lung cancer	9.98e-05	0.000551	CcSEcCtD
Alosetron—Nausea—Irinotecan—lung cancer	9.95e-05	0.000549	CcSEcCtD
Alosetron—Pain—Docetaxel—lung cancer	9.9e-05	0.000547	CcSEcCtD
Alosetron—Constipation—Docetaxel—lung cancer	9.9e-05	0.000547	CcSEcCtD
Alosetron—Asthenia—Paclitaxel—lung cancer	9.8e-05	0.000541	CcSEcCtD
Alosetron—Nausea—Gemcitabine—lung cancer	9.69e-05	0.000535	CcSEcCtD
Alosetron—Vomiting—Cisplatin—lung cancer	9.67e-05	0.000534	CcSEcCtD
Alosetron—Rash—Cisplatin—lung cancer	9.59e-05	0.00053	CcSEcCtD
Alosetron—Dermatitis—Cisplatin—lung cancer	9.58e-05	0.000529	CcSEcCtD
Alosetron—Feeling abnormal—Docetaxel—lung cancer	9.54e-05	0.000527	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—lung cancer	9.49e-05	0.000524	CcSEcCtD
Alosetron—Malaise—Methotrexate—lung cancer	9.22e-05	0.000509	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—lung cancer	9.08e-05	0.000502	CcSEcCtD
Alosetron—Nausea—Cisplatin—lung cancer	9.03e-05	0.000499	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—lung cancer	8.99e-05	0.000496	CcSEcCtD
Alosetron—Cough—Methotrexate—lung cancer	8.92e-05	0.000493	CcSEcCtD
Alosetron—Vomiting—Etoposide—lung cancer	8.86e-05	0.000489	CcSEcCtD
Alosetron—Rash—Etoposide—lung cancer	8.78e-05	0.000485	CcSEcCtD
Alosetron—Dermatitis—Etoposide—lung cancer	8.77e-05	0.000485	CcSEcCtD
Alosetron—Headache—Etoposide—lung cancer	8.73e-05	0.000482	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—lung cancer	8.72e-05	0.000482	CcSEcCtD
Alosetron—Myalgia—Methotrexate—lung cancer	8.7e-05	0.000481	CcSEcCtD
Alosetron—Vomiting—Paclitaxel—lung cancer	8.68e-05	0.00048	CcSEcCtD
Alosetron—Rash—Paclitaxel—lung cancer	8.61e-05	0.000476	CcSEcCtD
Alosetron—Dermatitis—Paclitaxel—lung cancer	8.6e-05	0.000475	CcSEcCtD
Alosetron—Discomfort—Methotrexate—lung cancer	8.6e-05	0.000475	CcSEcCtD
Alosetron—Headache—Paclitaxel—lung cancer	8.56e-05	0.000473	CcSEcCtD
Alosetron—Hypersensitivity—Docetaxel—lung cancer	8.53e-05	0.000471	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—lung cancer	8.51e-05	0.00047	CcSEcCtD
Alosetron—Confusional state—Methotrexate—lung cancer	8.41e-05	0.000465	CcSEcCtD
Alosetron—Asthenia—Docetaxel—lung cancer	8.31e-05	0.000459	CcSEcCtD
Alosetron—Infection—Methotrexate—lung cancer	8.29e-05	0.000458	CcSEcCtD
Alosetron—Nausea—Etoposide—lung cancer	8.27e-05	0.000457	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—lung cancer	8.21e-05	0.000454	CcSEcCtD
Alosetron—Nausea—Paclitaxel—lung cancer	8.11e-05	0.000448	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—lung cancer	8.1e-05	0.000448	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—lung cancer	8.07e-05	0.000446	CcSEcCtD
Alosetron—Malaise—Doxorubicin—lung cancer	7.98e-05	0.000441	CcSEcCtD
Alosetron—Cough—Doxorubicin—lung cancer	7.72e-05	0.000427	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—lung cancer	7.64e-05	0.000422	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—lung cancer	7.6e-05	0.00042	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—lung cancer	7.54e-05	0.000416	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—lung cancer	7.51e-05	0.000415	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—lung cancer	7.45e-05	0.000411	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—lung cancer	7.37e-05	0.000407	CcSEcCtD
Alosetron—Vomiting—Docetaxel—lung cancer	7.36e-05	0.000407	CcSEcCtD
Alosetron—Rash—Docetaxel—lung cancer	7.3e-05	0.000403	CcSEcCtD
Alosetron—Dermatitis—Docetaxel—lung cancer	7.29e-05	0.000403	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—lung cancer	7.28e-05	0.000402	CcSEcCtD
Alosetron—Headache—Docetaxel—lung cancer	7.25e-05	0.000401	CcSEcCtD
Alosetron—Fatigue—Methotrexate—lung cancer	7.19e-05	0.000397	CcSEcCtD
Alosetron—Infection—Doxorubicin—lung cancer	7.18e-05	0.000396	CcSEcCtD
Alosetron—Pain—Methotrexate—lung cancer	7.13e-05	0.000394	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—lung cancer	7.02e-05	0.000388	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—lung cancer	6.98e-05	0.000386	CcSEcCtD
Alosetron—Nausea—Docetaxel—lung cancer	6.88e-05	0.00038	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—lung cancer	6.88e-05	0.00038	CcSEcCtD
Alosetron—Urticaria—Methotrexate—lung cancer	6.63e-05	0.000366	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.58e-05	0.000364	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—lung cancer	6.23e-05	0.000344	CcSEcCtD
Alosetron—Pain—Doxorubicin—lung cancer	6.18e-05	0.000341	CcSEcCtD
Alosetron—Constipation—Doxorubicin—lung cancer	6.18e-05	0.000341	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—lung cancer	6.15e-05	0.00034	CcSEcCtD
Alosetron—Asthenia—Methotrexate—lung cancer	5.99e-05	0.000331	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—lung cancer	5.95e-05	0.000329	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—lung cancer	5.74e-05	0.000317	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—lung cancer	5.32e-05	0.000294	CcSEcCtD
Alosetron—Vomiting—Methotrexate—lung cancer	5.3e-05	0.000293	CcSEcCtD
Alosetron—Rash—Methotrexate—lung cancer	5.26e-05	0.000291	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—lung cancer	5.26e-05	0.00029	CcSEcCtD
Alosetron—Headache—Methotrexate—lung cancer	5.23e-05	0.000289	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—lung cancer	5.18e-05	0.000286	CcSEcCtD
Alosetron—Nausea—Methotrexate—lung cancer	4.96e-05	0.000274	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—lung cancer	4.59e-05	0.000254	CcSEcCtD
Alosetron—Rash—Doxorubicin—lung cancer	4.56e-05	0.000252	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—lung cancer	4.55e-05	0.000251	CcSEcCtD
Alosetron—Headache—Doxorubicin—lung cancer	4.53e-05	0.00025	CcSEcCtD
Alosetron—Nausea—Doxorubicin—lung cancer	4.29e-05	0.000237	CcSEcCtD
Alosetron—CYP2E1—Metabolism—CNDP2—lung cancer	3.07e-05	0.000468	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM2—lung cancer	3.07e-05	0.000468	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.07e-05	0.000467	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AZIN2—lung cancer	3.05e-05	0.000464	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—COL4A3BP—lung cancer	3.05e-05	0.000464	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ATP5H—lung cancer	3.03e-05	0.000462	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.03e-05	0.000461	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—POMC—lung cancer	3.02e-05	0.00046	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTMR3—lung cancer	2.99e-05	0.000455	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PGAM1—lung cancer	2.91e-05	0.000443	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	2.84e-05	0.000433	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.82e-05	0.00043	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.79e-05	0.000424	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.78e-05	0.000424	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP2A7—lung cancer	2.78e-05	0.000423	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	2.75e-05	0.000419	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SDC4—lung cancer	2.72e-05	0.000414	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLBD1—lung cancer	2.7e-05	0.000412	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.67e-05	0.000407	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.66e-05	0.000405	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.64e-05	0.000402	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ATP5H—lung cancer	2.59e-05	0.000395	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—POMC—lung cancer	2.58e-05	0.000393	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—RRM1—lung cancer	2.48e-05	0.000377	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA3—lung cancer	2.48e-05	0.000377	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HSD17B10—lung cancer	2.47e-05	0.000376	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.38e-05	0.000363	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.35e-05	0.000358	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AZIN2—lung cancer	2.35e-05	0.000358	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—B4GALT5—lung cancer	2.33e-05	0.000354	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLBD1—lung cancer	2.31e-05	0.000352	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CKB—lung cancer	2.3e-05	0.00035	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.27e-05	0.000346	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA4—lung cancer	2.26e-05	0.000345	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA2—lung cancer	2.21e-05	0.000336	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM2—lung cancer	2.16e-05	0.000329	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CNDP2—lung cancer	2.16e-05	0.000329	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA1—lung cancer	2.13e-05	0.000324	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HSD17B10—lung cancer	2.11e-05	0.000322	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCC3—lung cancer	2.1e-05	0.000321	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTMR3—lung cancer	2.1e-05	0.00032	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PGAM1—lung cancer	2.05e-05	0.000312	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKR1C1—lung cancer	2.04e-05	0.00031	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ATP5H—lung cancer	2e-05	0.000305	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—POMC—lung cancer	1.99e-05	0.000304	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—UGT1A1—lung cancer	1.98e-05	0.000301	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CKB—lung cancer	1.96e-05	0.000299	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2A7—lung cancer	1.95e-05	0.000298	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SDC4—lung cancer	1.91e-05	0.000291	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GNG11—lung cancer	1.91e-05	0.000291	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM2—lung cancer	1.85e-05	0.000281	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CNDP2—lung cancer	1.85e-05	0.000281	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALDOA—lung cancer	1.82e-05	0.000277	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTMR3—lung cancer	1.8e-05	0.000274	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLBD1—lung cancer	1.78e-05	0.000271	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOA3—lung cancer	1.76e-05	0.000269	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PGAM1—lung cancer	1.75e-05	0.000267	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—RRM1—lung cancer	1.74e-05	0.000265	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA3—lung cancer	1.74e-05	0.000265	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADCY1—lung cancer	1.72e-05	0.000261	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCG2—lung cancer	1.72e-05	0.000261	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ENO2—lung cancer	1.68e-05	0.000256	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HPGDS—lung cancer	1.68e-05	0.000256	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPP2R1B—lung cancer	1.67e-05	0.000255	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2A7—lung cancer	1.67e-05	0.000254	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—B4GALT5—lung cancer	1.64e-05	0.000249	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SDC4—lung cancer	1.63e-05	0.000249	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTT1—lung cancer	1.63e-05	0.000249	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HSD17B10—lung cancer	1.63e-05	0.000248	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP2A6—lung cancer	1.61e-05	0.000246	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GCLC—lung cancer	1.61e-05	0.000246	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA4—lung cancer	1.59e-05	0.000243	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.56e-05	0.000237	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA2—lung cancer	1.55e-05	0.000236	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ENO1—lung cancer	1.53e-05	0.000233	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CKB—lung cancer	1.52e-05	0.000231	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA1—lung cancer	1.5e-05	0.000228	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—RRM1—lung cancer	1.49e-05	0.000227	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA3—lung cancer	1.49e-05	0.000227	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCC3—lung cancer	1.48e-05	0.000226	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKR1C1—lung cancer	1.43e-05	0.000218	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM2—lung cancer	1.42e-05	0.000217	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CNDP2—lung cancer	1.42e-05	0.000217	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—B4GALT5—lung cancer	1.4e-05	0.000213	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—UGT1A1—lung cancer	1.39e-05	0.000212	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTMR3—lung cancer	1.39e-05	0.000211	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA4—lung cancer	1.36e-05	0.000207	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NQO1—lung cancer	1.36e-05	0.000207	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PGAM1—lung cancer	1.35e-05	0.000206	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GNG11—lung cancer	1.34e-05	0.000204	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.34e-05	0.000203	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.33e-05	0.000203	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA2—lung cancer	1.33e-05	0.000202	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2A7—lung cancer	1.29e-05	0.000196	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA1—lung cancer	1.28e-05	0.000195	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDOA—lung cancer	1.28e-05	0.000195	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCC3—lung cancer	1.27e-05	0.000193	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SDC4—lung cancer	1.26e-05	0.000192	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOA3—lung cancer	1.24e-05	0.000189	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKR1C1—lung cancer	1.23e-05	0.000187	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—STK11—lung cancer	1.22e-05	0.000186	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.22e-05	0.000186	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADCY1—lung cancer	1.21e-05	0.000184	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCG2—lung cancer	1.21e-05	0.000184	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—UGT1A1—lung cancer	1.19e-05	0.000181	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HPGDS—lung cancer	1.18e-05	0.00018	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ENO2—lung cancer	1.18e-05	0.00018	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.18e-05	0.000179	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.16e-05	0.000177	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—RRM1—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA3—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTT1—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GNG11—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.14e-05	0.000174	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2A6—lung cancer	1.13e-05	0.000173	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GCLC—lung cancer	1.13e-05	0.000173	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—lung cancer	1.13e-05	0.000172	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.13e-05	0.000172	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAT—lung cancer	1.1e-05	0.000168	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDOA—lung cancer	1.09e-05	0.000166	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—B4GALT5—lung cancer	1.08e-05	0.000164	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ENO1—lung cancer	1.08e-05	0.000164	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.07e-05	0.000163	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCB1—lung cancer	1.07e-05	0.000163	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOA3—lung cancer	1.06e-05	0.000161	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.06e-05	0.000161	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TYMS—lung cancer	1.05e-05	0.00016	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA4—lung cancer	1.05e-05	0.00016	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.04e-05	0.000159	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—lung cancer	1.04e-05	0.000158	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADCY1—lung cancer	1.03e-05	0.000157	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCG2—lung cancer	1.03e-05	0.000157	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA2—lung cancer	1.02e-05	0.000156	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HPGDS—lung cancer	1.01e-05	0.000154	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ENO2—lung cancer	1.01e-05	0.000154	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.01e-05	0.000153	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.92e-06	0.000151	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA1—lung cancer	9.88e-06	0.00015	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP1A1—lung cancer	9.86e-06	0.00015	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTT1—lung cancer	9.81e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ERCC2—lung cancer	9.77e-06	0.000149	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCC3—lung cancer	9.77e-06	0.000149	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2A6—lung cancer	9.7e-06	0.000148	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GCLC—lung cancer	9.7e-06	0.000148	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.66e-06	0.000147	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2E1—lung cancer	9.65e-06	0.000147	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NQO1—lung cancer	9.54e-06	0.000145	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKR1C1—lung cancer	9.46e-06	0.000144	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.34e-06	0.000142	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.26e-06	0.000141	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ENO1—lung cancer	9.19e-06	0.00014	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—UGT1A1—lung cancer	9.18e-06	0.00014	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.16e-06	0.00014	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.04e-06	0.000138	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GNG11—lung cancer	8.85e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—STK11—lung cancer	8.6e-06	0.000131	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOA1—lung cancer	8.46e-06	0.000129	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDOA—lung cancer	8.43e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2E1—lung cancer	8.25e-06	0.000126	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOA3—lung cancer	8.18e-06	0.000125	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NQO1—lung cancer	8.15e-06	0.000124	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.07e-06	0.000123	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.98e-06	0.000122	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADCY1—lung cancer	7.96e-06	0.000121	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCG2—lung cancer	7.96e-06	0.000121	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—lung cancer	7.96e-06	0.000121	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.91e-06	0.00012	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HPGDS—lung cancer	7.81e-06	0.000119	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ENO2—lung cancer	7.81e-06	0.000119	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.76e-06	0.000118	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAT—lung cancer	7.74e-06	0.000118	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CG—lung cancer	7.72e-06	0.000118	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.7e-06	0.000117	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTT1—lung cancer	7.57e-06	0.000115	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCB1—lung cancer	7.53e-06	0.000115	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCLC—lung cancer	7.48e-06	0.000114	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2A6—lung cancer	7.48e-06	0.000114	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TYMS—lung cancer	7.4e-06	0.000113	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—STK11—lung cancer	7.35e-06	0.000112	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—POMC—lung cancer	7.35e-06	0.000112	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—lung cancer	7.31e-06	0.000111	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CREBBP—lung cancer	7.16e-06	0.000109	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ENO1—lung cancer	7.1e-06	0.000108	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP1A1—lung cancer	6.93e-06	0.000106	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.9e-06	0.000105	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ERCC2—lung cancer	6.88e-06	0.000105	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—lung cancer	6.8e-06	0.000104	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CD—lung cancer	6.79e-06	0.000103	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALB—lung cancer	6.7e-06	0.000102	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAT—lung cancer	6.62e-06	0.000101	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.58e-06	0.0001	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCB1—lung cancer	6.44e-06	9.8e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2E1—lung cancer	6.36e-06	9.69e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TYMS—lung cancer	6.32e-06	9.63e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NQO1—lung cancer	6.29e-06	9.58e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—lung cancer	6.25e-06	9.52e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOA1—lung cancer	5.95e-06	9.06e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP1A1—lung cancer	5.92e-06	9.02e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CB—lung cancer	5.91e-06	9.01e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ERCC2—lung cancer	5.88e-06	8.95e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS2—lung cancer	5.86e-06	8.93e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.7e-06	8.67e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—STK11—lung cancer	5.67e-06	8.64e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CG—lung cancer	5.43e-06	8.27e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—lung cancer	5.25e-06	7.99e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—POMC—lung cancer	5.17e-06	7.87e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTEN—lung cancer	5.11e-06	7.78e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAT—lung cancer	5.11e-06	7.78e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOA1—lung cancer	5.08e-06	7.74e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CREBBP—lung cancer	5.03e-06	7.67e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCB1—lung cancer	4.97e-06	7.57e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TYMS—lung cancer	4.88e-06	7.43e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—EP300—lung cancer	4.87e-06	7.42e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.87e-06	7.41e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—lung cancer	4.82e-06	7.35e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CD—lung cancer	4.77e-06	7.27e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALB—lung cancer	4.71e-06	7.18e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CG—lung cancer	4.64e-06	7.07e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP1A1—lung cancer	4.57e-06	6.96e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ERCC2—lung cancer	4.53e-06	6.91e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—POMC—lung cancer	4.42e-06	6.73e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CREBBP—lung cancer	4.3e-06	6.55e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CB—lung cancer	4.16e-06	6.34e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS2—lung cancer	4.12e-06	6.28e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CD—lung cancer	4.08e-06	6.21e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALB—lung cancer	4.03e-06	6.13e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOA1—lung cancer	3.92e-06	5.97e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CA—lung cancer	3.61e-06	5.49e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTEN—lung cancer	3.6e-06	5.48e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CG—lung cancer	3.58e-06	5.45e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CB—lung cancer	3.56e-06	5.42e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS2—lung cancer	3.52e-06	5.37e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—EP300—lung cancer	3.43e-06	5.22e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—POMC—lung cancer	3.41e-06	5.19e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CREBBP—lung cancer	3.32e-06	5.06e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CD—lung cancer	3.15e-06	4.79e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALB—lung cancer	3.11e-06	4.73e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTEN—lung cancer	3.07e-06	4.68e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—lung cancer	2.95e-06	4.49e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—EP300—lung cancer	2.93e-06	4.46e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CB—lung cancer	2.74e-06	4.18e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS2—lung cancer	2.72e-06	4.14e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CA—lung cancer	2.54e-06	3.86e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTEN—lung cancer	2.37e-06	3.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—EP300—lung cancer	2.26e-06	3.44e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CA—lung cancer	2.17e-06	3.3e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—lung cancer	2.07e-06	3.16e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—lung cancer	1.77e-06	2.7e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CA—lung cancer	1.67e-06	2.55e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—lung cancer	1.37e-06	2.08e-05	CbGpPWpGaD
